Suppr超能文献

相似文献

1
Chronic Liver Diseases and the Microbiome-Translating Our Knowledge of Gut Microbiota to Management of Chronic Liver Disease.
Gastroenterology. 2021 Jan;160(2):556-572. doi: 10.1053/j.gastro.2020.10.056. Epub 2020 Nov 28.
2
Review article: the gut microbiome as a therapeutic target in the pathogenesis and treatment of chronic liver disease.
Aliment Pharmacol Ther. 2018 Jan;47(2):192-202. doi: 10.1111/apt.14397. Epub 2017 Oct 30.
5
The role of gut microbiota in intestinal and liver diseases.
Lab Anim. 2019 Jun;53(3):271-280. doi: 10.1177/0023677218818605. Epub 2018 Dec 22.
6
Intestinal microbiota in liver disease.
Best Pract Res Clin Gastroenterol. 2016 Feb;30(1):133-42. doi: 10.1016/j.bpg.2016.02.004. Epub 2016 Feb 9.
7
The Progression of Microbiome Therapeutics for the Management of Gastrointestinal Diseases and Beyond.
Gastroenterology. 2024 Oct;167(5):885-902. doi: 10.1053/j.gastro.2024.05.004. Epub 2024 May 14.
8
Microbiome: Emerging Concepts in Patients with Chronic Liver Disease.
Clin Liver Dis. 2020 Aug;24(3):493-520. doi: 10.1016/j.cld.2020.04.006. Epub 2020 May 24.
10
The relevance of intestinal dysbiosis in liver transplant candidates.
Transpl Infect Dis. 2015 Apr;17(2):174-84. doi: 10.1111/tid.12352. Epub 2015 Mar 2.

引用本文的文献

3
Stem cell-based therapeutic strategies for liver aging.
Liver Res. 2025 Apr 15;9(2):118-131. doi: 10.1016/j.livres.2025.04.003. eCollection 2025 Jun.
5
Gut Microbial Dysbiosis and Implications in Solid Organ Transplantation.
Biomedicines. 2024 Dec 9;12(12):2792. doi: 10.3390/biomedicines12122792.
6
The future of clinical trials of gut microbiome therapeutics in cirrhosis.
JHEP Rep. 2024 Oct 10;7(1):101234. doi: 10.1016/j.jhepr.2024.101234. eCollection 2025 Jan.
7
The impact of traditional Chinese medicine and dietary compounds on modulating gut microbiota in hepatic fibrosis: A review.
Heliyon. 2024 Sep 26;10(19):e38339. doi: 10.1016/j.heliyon.2024.e38339. eCollection 2024 Oct 15.
8
NLRP3 Inflammasome in Acute and Chronic Liver Diseases.
Int J Mol Sci. 2024 Apr 20;25(8):4537. doi: 10.3390/ijms25084537.
9
Microbiota Therapy in Inflammatory Bowel Disease.
Visc Med. 2024 Apr;40(2):92-101. doi: 10.1159/000536254. Epub 2024 Jan 29.
10
Hepatic Fibrosis and Cancer: The Silent Threats of Metabolic Syndrome.
Diabetes Metab J. 2024 Mar;48(2):161-169. doi: 10.4093/dmj.2023.0240. Epub 2024 Jan 26.

本文引用的文献

1
A Universal Gut-Microbiome-Derived Signature Predicts Cirrhosis.
Cell Metab. 2020 Nov 3;32(5):901. doi: 10.1016/j.cmet.2020.10.015.
2
Cost-effectiveness of integrating gut microbiota analysis into hospitalisation prediction in cirrhosis.
GastroHep. 2020 Mar;2(2):79-86. doi: 10.1002/ygh2.390. Epub 2020 Feb 6.
3
Interaction of bacterial metagenome and virome in patients with cirrhosis and hepatic encephalopathy.
Gut. 2021 Jun;70(6):1162-1173. doi: 10.1136/gutjnl-2020-322470. Epub 2020 Sep 30.
4
Alterations in Gut Microbiome in Cirrhosis as Assessed by Quantitative Metagenomics: Relationship With Acute-on-Chronic Liver Failure and Prognosis.
Gastroenterology. 2021 Jan;160(1):206-218.e13. doi: 10.1053/j.gastro.2020.08.054. Epub 2020 Sep 14.
5
The Commensal Microbe Veillonella as a Marker for Response to an FGF19 Analog in NASH.
Hepatology. 2021 Jan;73(1):126-143. doi: 10.1002/hep.31523. Epub 2020 Dec 11.
7
Functional Microbiomics Reveals Alterations of the Gut Microbiome and Host Co-Metabolism in Patients With Alcoholic Hepatitis.
Hepatol Commun. 2020 Jun 19;4(8):1168-1182. doi: 10.1002/hep4.1537. eCollection 2020 Aug.
8
A Randomized Clinical Trial of Fecal Microbiota Transplant for Alcohol Use Disorder.
Hepatology. 2021 May;73(5):1688-1700. doi: 10.1002/hep.31496. Epub 2021 Mar 16.
10
Changes in the fecal bacterial microbiota associated with disease severity in alcoholic hepatitis patients.
Gut Microbes. 2020 Nov 9;12(1):1785251. doi: 10.1080/19490976.2020.1785251. Epub 2020 Jul 20.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验